Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2026-05-22 @ 4:01 PM
Study NCT ID:
NCT05183802
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2022-08-10
First Post:
2021-11-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Expanded Access Protocol for Setmelanotide for Treatment of Bardet-Biedl Syndrome (BBS)
Sponsor:
Rhythm Pharmaceuticals, Inc.
Organization: